Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group. 1997

K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Japan.

Cytomegalovirus (CMV) infection and CMV-associated disease were monitored using the CMV antigenemia assay in 72 patients who received allogeneic bone marrow transplantation (BMT), and their incidences were compared between related and unrelated donor transplant patients. The incidence of CMV infection after BMT was significantly higher in patients who received transplants from HLA-matched unrelated donors than from HLA-matched sibling donors (87% vs 53%, P < 0.05). CMV-associated disease developed in 73% of unrelated and in 14% of sibling donor transplant patients (P < 0.01). The peak levels of CMV antigenemia were significantly higher in unrelated donors than in sibling donor transplant patients (16 vs 1 CMV antigen-positive cells per 50000 WBCs, P < 0.01). The median number of CMV antigen-positive cells on first detection was also significantly higher in unrelated donor transplant patients (15 vs 1, P < 0.01). The detection of CMV antigen-positive cells preceded the development of CMV-associated disease in 18% of unrelated donor transplant patients, suggesting a lower predictive value of CMV antigenemia for subsequent CMV-associated disease in unrelated donor BMT. Careful monitoring and further studies are needed for the early diagnosis and prevention of CMV-associated disease in unrelated donor BMT.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D005260 Female Females
D006650 Histocompatibility Testing Identification of the major histocompatibility antigens of transplant DONORS and potential recipients, usually by serological tests. Donor and recipient pairs should be of identical ABO blood group, and in addition should be matched as closely as possible for HISTOCOMPATIBILITY ANTIGENS in order to minimize the likelihood of allograft rejection. (King, Dictionary of Genetics, 4th ed) Crossmatching, Tissue,HLA Typing,Tissue Typing,Crossmatchings, Tissue,HLA Typings,Histocompatibility Testings,Testing, Histocompatibility,Testings, Histocompatibility,Tissue Crossmatching,Tissue Crossmatchings,Tissue Typings,Typing, HLA,Typing, Tissue,Typings, HLA,Typings, Tissue
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
July 1997, Bone marrow transplantation,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
January 1993, Bone marrow transplantation,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
January 1993, Leukemia & lymphoma,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
April 2006, International journal of hematology,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
October 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
June 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
January 1996, [Rinsho ketsueki] The Japanese journal of clinical hematology,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
January 1999, Haematologica,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
August 1997, Nederlands tijdschrift voor geneeskunde,
K Takenaka, and H Gondo, and K Tanimoto, and K Nagafuji, and T Fujisaki, and S Mizuno, and T Miyamoto, and T Okamura, and S Hayashi, and T Eto, and K Osaki, and K Yamasaki, and T Shibuya, and N Harada, and T Teshima, and E Matsuishi, and T Minematsu, and Y Minamishima, and M Harada, and Y Niho
December 1991, Bone marrow transplantation,
Copied contents to your clipboard!